| Value | ₹25.91 Cr |
|---|
BSE filing, NSE: TRANSCHEM. Summary written from the filing by ALFA Finder's alert engine.
Transchem Ltd: key numbers
- Share price
- ₹405.45
- Market cap
- ₹496.3 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹4.30 Cr
- P/E (TTM)
- 73.8×Sector 26.2×
- Promoter holding
- 56.45%+0.00% QoQ
- FII holding
- 0.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Transchem Ltd
All →Transchem Board Meeting Date
Transchem Ltd intimated BSE that its Board meeting is scheduled for November 4, 2026 to consider un-audited Q2/H1 results. The trading window for designated persons is closed from October 1, 2026.
Transchem Other Announcement
Transchem Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. The submission includes minor composition updates to the company's promoter group.
Transchem Annual General Meeting
Transchem Limited submitted the minutes of its 49th Annual General Meeting held on September 05, 2026. Shareholders approved audited financial statements and the re-appointment of Director Mahesh Suresh Rananavre.
Transchem Annual General Meeting
Transchem Limited held its 49th Annual General Meeting on September 05, 2026. Members considered agenda items, including financial statement adoption and related party transaction approvals.
Transchem Other Announcement
Transchem Limited has amended its 'Code of Conduct for Prevention of Insider Trading' in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.
Transchem Q1 FY27 Results: Net Profit ₹3.4 Cr, Up 240.0% YoY
Transchem Ltd reported net profit of ₹3.4 Cr (+240.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹3.4 Cr · +240.0% YoY
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr